Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor

Some patients treated with dual antiplatelet therapy (DAPT) following acute coronary syndrome (ACS) can still exhibit heightened residual platelet reactivity (HRPR), which is potentially linked to adverse vascular outcomes. Better tailored DAPT strategies are needed to address this medical need. Aim...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nikita Lomakin, Anna Rudakova, Liudmila Buryachkovskaya, Victor Serebruany
Formato: article
Lenguaje:EN
Publicado: Radcliffe Medical Media 2019
Materias:
Acceso en línea:https://doaj.org/article/a91ec16800854a1d82afd0cd6c911f1e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!